PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial
Clinical trial NCT05605613 · UNKNOWN
Trial details
- NCT number
- NCT05605613
- Sponsor
- Xuhua Duan
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-29
- Primary completion
- 2023-11-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.